130 related articles for article (PubMed ID: 21434447)
1. [Study on formulation of naoxuekang dispersible tablets].
Fu MY; Lv ZF; Chen YZ; Xie QC; Shen L
Zhong Yao Cai; 2010 Nov; 33(11):1800-3. PubMed ID: 21434447
[TBL] [Abstract][Full Text] [Related]
2. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
3. Evaluation about wettability, water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration.
Yang B; Wei C; Yang Y; Wang Q; Li S
Drug Dev Ind Pharm; 2018 Sep; 44(9):1417-1425. PubMed ID: 29557692
[TBL] [Abstract][Full Text] [Related]
4. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
Lin SY; Lin KH; Li MJ
J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
[TBL] [Abstract][Full Text] [Related]
5. Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables.
Mostafa HF; Ibrahim MA; Sakr A
Pharm Dev Technol; 2013; 18(2):454-63. PubMed ID: 22881389
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of disintegrants functionality for orodispersible mini tablets.
Soulairol I; Chaheen M; Tarlier N; Aubert A; Bataille B; Sharkawi T
Drug Dev Ind Pharm; 2017 Nov; 43(11):1770-1779. PubMed ID: 28581832
[TBL] [Abstract][Full Text] [Related]
7. The use of micronized cellulose disintegrants as insoluble swellable matrices for sustained-release tablets.
Nakagami H; Nada M
Drug Des Deliv; 1991 Jul; 7(4):321-32. PubMed ID: 1930623
[TBL] [Abstract][Full Text] [Related]
8. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K
J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
[TBL] [Abstract][Full Text] [Related]
9. [Preparation of Zhongjiefeng dispersible tablets].
Wu ZF; He W; Li Y
Zhong Yao Cai; 2008 Oct; 31(10):1557-9. PubMed ID: 19230415
[TBL] [Abstract][Full Text] [Related]
10. Review of Disintegrants and the Disintegration Phenomena.
Desai PM; Liew CV; Heng PWS
J Pharm Sci; 2016 Sep; 105(9):2545-2555. PubMed ID: 27506604
[TBL] [Abstract][Full Text] [Related]
11. Design and content determination of Genhuang dispersible tablet herbal formulation.
Xin RH; Liang G; Zheng JF
Pak J Pharm Sci; 2017 Mar; 30(2(Suppl.)):655-661. PubMed ID: 28650336
[TBL] [Abstract][Full Text] [Related]
12. Development of swelling/floating gastroretentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl cellulose for Losartan and its clinical relevance in healthy volunteers with CYP2C9 polymorphism.
Chen RN; Ho HO; Yu CY; Sheu MT
Eur J Pharm Sci; 2010 Jan; 39(1-3):82-9. PubMed ID: 19903527
[TBL] [Abstract][Full Text] [Related]
13. Development of immediate release Rupatadine fumarate 10 mg tablets: A Quality by Design (QbD) approach.
Castillo Henríquez L; Vargas Zúñiga R; Carazo Berrocal G; Madrigal Redondo G; Calvo Guzmán B; Baltodano Viales E
Drug Dev Ind Pharm; 2019 Oct; 45(10):1674-1681. PubMed ID: 31378098
[No Abstract] [Full Text] [Related]
14. Cyclodextrin polymer, a new tablet disintegrating agent.
Fenyvest E; Antal B; Zsadon B; Szejtli J
Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.
Bi Y; Sunada H; Yonezawa Y; Danjo K; Otsuka A; Iida K
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2121-7. PubMed ID: 8945778
[TBL] [Abstract][Full Text] [Related]
16. Influence of disintegrants in different substrate physical form on dimensional recovery of multi-component tablet.
Sarkar S; Ooi SM; Liew CV; Tan BX; Heng PW
Int J Pharm; 2014 Nov; 475(1-2):558-65. PubMed ID: 25218488
[TBL] [Abstract][Full Text] [Related]
17. Effect of disintegrant type upon the relationship between compressional pressure and dissolution efficiency.
Khan KA; Rooke DJ
J Pharm Pharmacol; 1976 Aug; 28(8):633-6. PubMed ID: 11313
[TBL] [Abstract][Full Text] [Related]
18. Pulse release of doxazosin from hydroxyethylcellulose compression coated tablet: mechanistic and in vivo study.
Biswas N; Guha A; Sahoo RK; Kuotsu K
Int J Biol Macromol; 2015 Jan; 72():537-43. PubMed ID: 25179280
[TBL] [Abstract][Full Text] [Related]
19. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.
Kasliwal N; Negi JS; Jugran V; Jain R
Arch Pharm Res; 2011 Oct; 34(10):1691-700. PubMed ID: 22076769
[TBL] [Abstract][Full Text] [Related]
20. Co-Processed Excipients for Dispersible Tablets-Part 2: Patient Acceptability.
Dziemidowicz K; Lopez FL; Bowles BJ; Edwards AJ; Ernest TB; Orlu M; Tuleu C
AAPS PharmSciTech; 2018 Aug; 19(6):2646-2657. PubMed ID: 29943280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
